Drug Profile
Research Programme: proteins inhibitors - SBI Biotech
Latest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator SBI Biotech
- Class Small molecules
- Mechanism of Action CDC7 protein kinase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Cancer in Japan
- 29 Sep 2008 Preclinical trials in Cancer in Japan (unspecified route)